The label is designed for emissions-free variable marking of extremely narrow carpule surfaces, usually about five millimeters. The CLF features a thin composition and flexible structure right for
Perrigo will immediately begin the shipment of Morphine sulfate oral solution, a Schedule II controlled substance. Morphine sulfate oral solution is indicated for the relief of moderate to
According to the MOU, Green Cross will receive an exclusive license to commercialize Aquavit’s IBX-001 in Korea and will support the product development, registration and manufacturing. Aquavit chief
Under the agreement, US Renal Care will purchase Omontys for use within its organization and provides for discounts and rebates on the product, subject to certain requirements. The
As a result of the achievement within four years, Pfizer achieved $85m in annualized project savings. Pfizer health and safety global environment vice president Steve Brooks said environmental
The randomized, double blind, placebo controlled study will assess the safety and efficacy of its PLX cells, through intramuscular injections, for the regeneration of injured gluteal musculature following
The agreement includes an upfront payment of $1m with future milestone payments of up to $3m, alongside escalating supply volumes over the next five years. Genedrive provides a
The study, conducted with a new class of antibiotics designed to inhibit staphylococcal fatty acid biosynthesis by means of a new drug target, the fatty acid synthase II
ABP said its patented Accu-Break tablets can be split easily by hand into exact smaller doses, which will make it easier and safer for patients and caregivers to
The Phase 2 study will enroll approximately 20 patients who will receive etirinotecan pegol once every three weeks as monotherapy. Stanford Cancer Institute professor of neurology and neurosurgery,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.